Andrew R. Robbins, COO at ARRAY BIOPHARMA INC (ARRY), sold 479,252 shares at $20.03 ($9.6M) on 2019-02-06, disclosed to the SEC on 2019-02-08.
Open-market sale of $9.6M ARRY by COO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.03 | 239,626 | $4.8M | 50.0% |
| 2 | $20.03 | 239,626 | $4.8M | 50.0% |
| Total | $20.03 avg | 479,252 | $9.6M | 100% |
| Filing → |